{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:44:51Z","timestamp":1776689091487,"version":"3.51.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T00:00:00Z","timestamp":1459123200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0235-1","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T11:30:22Z","timestamp":1459164622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study"],"prefix":"10.1186","volume":"16","author":[{"given":"Vigdis","family":"Vanbeselaere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Truyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Elli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Buntinx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrie","family":"De Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Degryse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Henrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert","family":"Vaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,28]]},"reference":[{"key":"235_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","volume":"27","author":"J Heeringa","year":"2006","unstructured":"Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949\u201353.","journal-title":"Eur Heart J"},{"issue":"35","key":"235_CR2","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","volume":"34","author":"PB Krijthe","year":"2013","unstructured":"Krijthe PB, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746\u201351.","journal-title":"Eur Heart J"},{"issue":"2","key":"235_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/1753944712464101","volume":"7","author":"JC LaMori","year":"2013","unstructured":"LaMori JC, Mody SH, Gross HJ, et al. Burden of comorbidities among patients with atrial fibrillation. Ther Adv Cardiovasc Dis. 2013;7(2):53\u201362.","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"12","key":"235_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857\u201367.","journal-title":"Ann Intern Med"},{"issue":"22","key":"235_CR5","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"BF Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. JAMA. 2001;285(22):2864\u201370.","journal-title":"JAMA"},{"issue":"2","key":"235_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GH Lip","year":"2010","unstructured":"Lip GH, Nieuwlaat R, Pisters R, Lane DA, Crijns HM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"key":"235_CR7","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","volume":"104","author":"ACC\/AHA\/ESC committee members","year":"2001","unstructured":"ACC\/AHA\/ESC committee members et al. ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation. Circulation. 2001;104:2118\u201350.","journal-title":"Circulation"},{"key":"235_CR8","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","year":"2010","unstructured":"The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Guidelines for the management of atrial fibrillation. Eur Heart J. 2010;31:2369\u2013429.","journal-title":"Eur Heart J"},{"key":"235_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/heartjnl-2012-302843","volume":"99","author":"AC Scowcroft","year":"2013","unstructured":"Scowcroft AC, Lee S, Mant J. Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000\u20132009. Heart. 2013;99:127\u201332.","journal-title":"Heart"},{"key":"235_CR10","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.amjcard.2011.06.017","volume":"108","author":"PS Chan","year":"2011","unstructured":"Chan PS, Maddox TM, Tang F, et al. Practice-level variation in warfarin use among outpatients with atrial fibrillation (from the NCDR PINNACLE program). Am J Cardiol. 2011;108:1136\u201340.","journal-title":"Am J Cardiol"},{"issue":"Suppl. 1","key":"235_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/13814780802436093","volume":"14","author":"A Uijen","year":"2008","unstructured":"Uijen A, Van de Lisdonk E. Multimorbidity in primary care: prevalence and trend over the last 20\u00a0years. Eur J Gen Pract. 2008;14 Suppl 1:28\u201332.","journal-title":"Eur J Gen Pract"},{"key":"235_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1472-6947-14-48","volume":"14","author":"C Truyers","year":"2014","unstructured":"Truyers C, Goderis G, Dewitte H, et al. The Intego database: background, methods and basic results of a Flemish general practice-based continuous morbidity registration project. BMC Med Inform Decis Mak. 2014;14:48.","journal-title":"BMC Med Inform Decis Mak"},{"key":"235_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0895-4356(02)00583-8","volume":"56","author":"MS Cepeda","year":"2003","unstructured":"Cepeda MS, Boston R, Farrar JT, Strom BL. Optimal matching with a variable number of controls vs. a fixed number of controls for a cohort study. trade-offs. J Clin Epidemiol. 2003;56:230\u20137.","journal-title":"J Clin Epidemiol"},{"key":"235_CR14","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"JD Easton","year":"2009","unstructured":"Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals. Stroke. 2009;40:2276\u201393.","journal-title":"Stroke"},{"key":"235_CR15","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0895-4356(96)00271-5","volume":"49","author":"W D\u2019Hoore","year":"1996","unstructured":"D\u2019Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson Comorbidity Index with administrative data bases. J Clin Epidemiol. 1996;49:1429\u201333.","journal-title":"J Clin Epidemiol"},{"key":"235_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/13814788.2014.914167","volume":"21","author":"P Boeckxstaens","year":"2015","unstructured":"Boeckxstaens P, Vaes B, Legrand D, Dalleur O, De Sutter A, Degryse JM. The relationship of multimorbidity with disability and frailty in the oldest patients: A cross-sectional analysis of three measures of multimorbidity in the BELFRAIL cohort. Eur J Gen Pract. 2015;21:39\u201344.","journal-title":"Eur J Gen Pract"},{"key":"235_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837\u201347.","journal-title":"Circulation"},{"issue":"5","key":"235_CR18","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","volume":"167","author":"J Ball","year":"2013","unstructured":"Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167(5):1807\u201324.","journal-title":"Int J Cardiol"},{"issue":"1","key":"235_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.gheart.2014.01.004","volume":"9","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Roth GA, Gillum RF, Mensah GA. Global burden of atrial fibrillation in developed and developing nations. Global Heart. 2014;9(1):113\u20139.","journal-title":"Global Heart"},{"key":"235_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","volume":"129","author":"AS Go","year":"2014","unstructured":"Go AS, Mozaffarian D, Roger VL, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. AHA statistical update: executive summary: heart disease and stroke statistics\u20142014 update: a report from the American Heart Association. Circulation. 2014;129:399\u2013410.","journal-title":"Circulation"},{"issue":"6","key":"235_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1212\/01.wnl.0000267275.68538.8d","volume":"69","author":"Stroke Risk in Atrial Fibrillation Working Group","year":"2007","unstructured":"Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology. 2007;69(6):546\u201354.","journal-title":"Neurology"},{"key":"235_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/ageing\/afl129","volume":"36","author":"A Rash","year":"2007","unstructured":"Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing. 2007;36:151\u20136.","journal-title":"Age Ageing"},{"key":"235_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","volume":"370","author":"J Mant","year":"2007","unstructured":"Mant J, Hobbs FDR, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in atrial fibrillation in the elderly community population: the Birmingham Atrial Fibrillation Treatment of the Aged Study (BAFTA), a randomized controlled trial. Lancet. 2007;370:493\u2013503.","journal-title":"Lancet"},{"key":"235_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/archinte.160.1.41","volume":"160","author":"TJ Bungard","year":"2000","unstructured":"Bungard TJ, Ghali WA, Teo KK, et al. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med. 2000;160:41\u20136.","journal-title":"Arch Intern Med"},{"issue":"4","key":"235_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/CIRCOUTCOMES.113.000127","volume":"6","author":"MW Cullen","year":"2013","unstructured":"Cullen MW, Kim S, Piccini Sr JP, et al. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Circ Cardiovasc Qual Outcomes. 2013;6(4):461\u20139.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"16","key":"235_CR26","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/heartjnl-2012-303472","volume":"99","author":"C Cowan","year":"2013","unstructured":"Cowan C, Healicon R, Robson I, et al. The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart. 2013;99(16):1166\u201372.","journal-title":"Heart"},{"key":"235_CR27","first-page":"137","volume":"11","author":"P Horsfield","year":"2003","unstructured":"Horsfield P, Teasdale S. Generating information from electronic patient records in general practice: a description of clinical care and gender inequalities in coronary heart disease using data from over two million patient records. Inform Prim Care. 2003;11:137\u201344.","journal-title":"Inform Prim Care"},{"key":"235_CR28","unstructured":"Health Interview Survey. 2008; https:\/\/his.wiv-isp.be\/SitePages\/Home.aspx (Accessed 20 Oct 2014)."}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0235-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-016-0235-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0235-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0235-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T21:25:40Z","timestamp":1567718740000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0235-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,28]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["235"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0235-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,28]]},"article-number":"61"}}